COVID Catalysts | Developing an at-home urine test to revolutionise cervical cancer screening скачать в хорошем качестве

COVID Catalysts | Developing an at-home urine test to revolutionise cervical cancer screening

Emma Crosbie, Professor of Gynaecological Oncology Cervical cancer is the second-leading cause of cancer-related death amongst women globally. But it’s also entirely preventable through HPV vaccination and screening. Screening however is an intimate procedure which only 7 in 10 UK women undergo. And in countries without screening programmes, cervical cancer remains a major cause of mortality among young women. But what if an at-home urine test could deliver the same results as those undertaken in medical settings? Research at Manchester is exploring that option - providing an accurate, cheaper, safe, and less-invasive method of testing in a time of screening backlogs caused by the COVID-19 pandemic. View all our flash lectures and find out more on our COVID Catalysts web page https://www.manchester.ac.uk/research... Cancer is one of five key areas of research focus at The University of Manchester. Our research beacons shine a light on Manchester's pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships which are helping to tackle some of the biggest global challenges facing the planet. Find out more about our Cancer research https://www.manchester.ac.uk/research... Filmed: 15/08/20